However, IL-15 SA predominantly expands NK, NKT, and mCD8+ lymphocytes, whereas preferential expansion of naïve and effector CD4 and CD8 T-lymphocyte populations, with therapies such as IL-7 [21,62], may provide more effective resistance to infection. The gene discussed is IL15; the disease is infection.